Difference between revisions of "Ultrasound CEUS BC"

From QIBA Wiki
Jump to: navigation, search
m (Reference Materials)
m (Reference Materials)
Line 35: Line 35:
  
 
Vendor Press Release
 
Vendor Press Release
[[File:QIBA Committee for Quantitative Contrast Enhanced Ultrasound_Final.pdf]]
+
*[[File:US-20160404-PR_221236_LUMASON_Liver-PR_0.pdf | FDA Approval for LUMASON® Press Release]]
  
 
*[[Media: QIBA Ultrasound Biomarkers Meeting, 03.29.2012-Dr. Hoyt.pdf|QIBA Ultrasound Biomarkers Meeting, 03.29.2012-Dr. Hoyt Presentation]]
 
*[[Media: QIBA Ultrasound Biomarkers Meeting, 03.29.2012-Dr. Hoyt.pdf|QIBA Ultrasound Biomarkers Meeting, 03.29.2012-Dr. Hoyt Presentation]]
 
*[[Media:x.pdf|text ]]
 
*[[Media:x.pdf|text ]]

Revision as of 18:48, 27 May 2016

Co-chairs: • Michalakis (Mike) A. Averkiou, PhD; Richard G. Barr, MD, PhD
Secretary: Julie Lisiecki
Roster: (Roster)

Project Snapshot

The Contrast Enhanced Ultrasound Biomarker Committee (CEUS BC) seeks to develop a quantitative imaging profile for CEUS imaging.

Under consideration:

Meetings/Call Summaries


Working Documents

Statistical Reference Documents

Workflow Documents

Historical Background - Formation of the Group

Reference Materials

Original Proposal to the QIBA Steering Committee

Vendor Press Release